From UBE3A to Angelman syndrome: a substrate perspective
about
A case of Pitt-Hopkins syndrome presented with Angelman-like syndromic phenotypesAngelman syndrome: Current and emerging therapies in 2016.Epigenetic Mistakes in Neurodevelopmental Disorders.Early Origin and Evolution of the Angelman Syndrome Ubiquitin Ligase Gene Ube3a.Amyloid Precursor Protein (APP) May Act as a Substrate and a Recognition Unit for CRL4CRBN and Stub1 E3 Ligases Facilitating Ubiquitination of Proteins Involved in Presynaptic Functions and NeurodegenerationActivity-Dependent Arc Expression and Homeostatic Synaptic Plasticity Are Altered in Neurons from a Mouse Model of Angelman Syndrome.Decreased Axon Caliber Underlies Loss of Fiber Tract Integrity, Disproportional Reductions in White Matter Volume, and Microcephaly in Angelman Syndrome Model Mice.The autism-linked UBE3A T485A mutant E3 ubiquitin ligase activates the Wnt/β-catenin pathway by inhibiting the proteasome.Excessive UBE3A dosage impairs retinoic acid signaling and synaptic plasticity in autism spectrum disorders.Enhanced operant extinction and prefrontal excitability in a mouse model of Angelman syndrome.Analysis of peripheral amyloid precursor protein in Angelman Syndrome.Lovastatin suppresses hyperexcitability and seizure in Angelman syndrome model.Common Defects of Spine Dynamics and Circuit Function in Neurodevelopmental Disorders: A Systematic Review of Findings From in Vivo Optical Imaging of Mouse Models.Subcellular organization of UBE3A in human cerebral cortex
P2860
Q37489230-927E3F4A-B00E-449B-9FC9-933BCCB66757Q39012491-EC304915-D214-4B76-BB76-4F27C48563F3Q39159445-FE429981-2D7F-47AC-BD62-7756A5098E98Q39191796-50F67FB3-1AFD-47A7-B549-2A38EDC2316FQ41045804-4FC48CE3-3BAE-49AD-98CF-DC65CB1E34CAQ41159863-035DC4FB-A32C-4C00-947F-752871C23ADFQ41919268-4D5F2EAA-8240-4F31-A318-5321A69523ABQ42510417-4AF3C257-6148-49D5-86C9-1390B00CFD83Q47998222-C9158C2D-E47E-4EBC-B358-6B982B21A54AQ50066459-A0827731-3A3C-4DE4-A155-F040C04EEA92Q52130370-D2171B90-ED7F-4804-B6F9-57BFDC7F6D69Q55228979-C44E2446-8B2F-46AF-B133-943CA4B40A64Q55474439-C5867C04-6F5D-4D7F-8C15-6E91CACCB381Q58589347-94C80078-427F-4490-8B75-B88F0AC7250E
P2860
From UBE3A to Angelman syndrome: a substrate perspective
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
From UBE3A to Angelman syndrome: a substrate perspective
@ast
From UBE3A to Angelman syndrome: a substrate perspective
@en
From UBE3A to Angelman syndrome: a substrate perspective
@nl
type
label
From UBE3A to Angelman syndrome: a substrate perspective
@ast
From UBE3A to Angelman syndrome: a substrate perspective
@en
From UBE3A to Angelman syndrome: a substrate perspective
@nl
prefLabel
From UBE3A to Angelman syndrome: a substrate perspective
@ast
From UBE3A to Angelman syndrome: a substrate perspective
@en
From UBE3A to Angelman syndrome: a substrate perspective
@nl
P2860
P356
P1476
From UBE3A to Angelman syndrome: a substrate perspective
@en
P2093
Gabrielle L Sell
Seth S Margolis
P2860
P356
10.3389/FNINS.2015.00322
P407
P577
2015-01-01T00:00:00Z